Literature DB >> 27941250

Impaired prohormone processing: a grand unified theory for features of Prader-Willi syndrome?

Joseph Polex-Wolf, Giles S H Yeo, Stephen O'Rahilly.   

Abstract

Prader-Willi syndrome (PWS) is a complex disorder that manifests with an array of phenotypes, such as hypotonia and difficulties in feeding during infancy and reduced energy expenditure, hyperphagia, and developmental delays later in life. While the genetic cause has long been known, it is still not clear how mutations at this locus produce this array of phenotypes. In this issue of the JCI, Burnett and colleagues used a comprehensive approach to gain insight into how PWS-associated mutations drive disease. Using neurons derived from PWS patient induced pluripotent stem cells (iPSCs) and mouse models, the authors provide evidence that neuroendocrine PWS-associated phenotypes may be linked to reduced expression of prohormone convertase 1 (PC1). While these compelling results support a critical role for PC1 deficiency in PWS, more work needs to be done to fully understand how and to what extent loss of this prohormone processing enzyme underlies disease manifestations in PWS patients.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27941250      PMCID: PMC5199707          DOI: 10.1172/JCI91307

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Reactivation of maternal SNORD116 cluster via SETDB1 knockdown in Prader-Willi syndrome iPSCs.

Authors:  Estela Cruvinel; Tara Budinetz; Noelle Germain; Stormy Chamberlain; Marc Lalande; Kristen Martins-Taylor
Journal:  Hum Mol Genet       Date:  2014-04-23       Impact factor: 6.150

2.  Attenuation of the polypeptide 7B2, prohormone convertase PC2, and vasopressin in the hypothalamus of some Prader-Willi patients: indications for a processing defect.

Authors:  B A Gabreëls; D F Swaab; D P de Kleijn; N G Seidah; J W Van de Loo; W J Van de Ven; G J Martens; F W van Leeuwen
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

3.  Reduced voluntary activity precedes adult-onset obesity in Nhlh2 knockout mice.

Authors:  Christopher A Coyle; Enxuan Jing; Trina Hosmer; J Bradley Powers; George Wade; Deborah J Good
Journal:  Physiol Behav       Date:  2002-11

4.  Paternally inherited microdeletion at 15q11.2 confirms a significant role for the SNORD116 C/D box snoRNA cluster in Prader-Willi syndrome.

Authors:  Angela L Duker; Blake C Ballif; Erawati V Bawle; Richard E Person; Sangeetha Mahadevan; Sarah Alliman; Regina Thompson; Ryan Traylor; Bassem A Bejjani; Lisa G Shaffer; Jill A Rosenfeld; Allen N Lamb; Trilochan Sahoo
Journal:  Eur J Hum Genet       Date:  2010-06-30       Impact factor: 4.246

Review 5.  Small mosaic deletion encompassing the snoRNAs and SNURF-SNRPN results in an atypical Prader-Willi syndrome phenotype.

Authors:  Britt-Marie Anderlid; Johanna Lundin; Helena Malmgren; Mikael Lehtihet; Ann Nordgren
Journal:  Am J Med Genet A       Date:  2013-12-05       Impact factor: 2.802

6.  Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia.

Authors:  Frederick A Kweh; Jennifer L Miller; Carlos R Sulsona; Clive Wasserfall; Mark Atkinson; Jonathan J Shuster; Anthony P Goldstone; Daniel J Driscoll
Journal:  Am J Med Genet A       Date:  2014-10-29       Impact factor: 2.802

7.  Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome.

Authors:  Lisa C Burnett; Charles A LeDuc; Carlos R Sulsona; Daniel Paull; Richard Rausch; Sanaa Eddiry; Jayne F Martin Carli; Michael V Morabito; Alicja A Skowronski; Gabriela Hubner; Matthew Zimmer; Liheng Wang; Robert Day; Brynn Levy; Ilene Fennoy; Beatrice Dubern; Christine Poitou; Karine Clement; Merlin G Butler; Michael Rosenbaum; Jean Pierre Salles; Maithe Tauber; Daniel J Driscoll; Dieter Egli; Rudolph L Leibel
Journal:  J Clin Invest       Date:  2016-12-12       Impact factor: 14.808

8.  Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader-Willi syndrome.

Authors:  Kathleen De Waele; Stacey L Ishkanian; Roberto Bogarin; Charmaine A Miranda; Mohammad A Ghatei; Stephen R Bloom; Danièle Pacaud; Jean-Pierre Chanoine
Journal:  Eur J Endocrinol       Date:  2008-07-04       Impact factor: 6.664

9.  Snord116 is critical in the regulation of food intake and body weight.

Authors:  Yue Qi; Louise Purtell; Melissa Fu; Nicola J Lee; Julia Aepler; Lei Zhang; Kim Loh; Ronaldo F Enriquez; Paul A Baldock; Sergei Zolotukhin; Lesley V Campbell; Herbert Herzog
Journal:  Sci Rep       Date:  2016-01-04       Impact factor: 4.379

Review 10.  PCSK1 Mutations and Human Endocrinopathies: From Obesity to Gastrointestinal Disorders.

Authors:  Pieter Stijnen; Bruno Ramos-Molina; Stephen O'Rahilly; John W M Creemers
Journal:  Endocr Rev       Date:  2016-05-17       Impact factor: 19.871

View more
  4 in total

Review 1.  Epigenetic therapy of Prader-Willi syndrome.

Authors:  Yuna Kim; Sung Eun Wang; Yong-Hui Jiang
Journal:  Transl Res       Date:  2019-03-05       Impact factor: 7.012

Review 2.  Proteins and proteases of Prader-Willi syndrome: a comprehensive review and perspectives.

Authors:  Sanjukta Basak; Ajoy Basak
Journal:  Biosci Rep       Date:  2022-06-30       Impact factor: 3.976

3.  Specific ZNF274 binding interference at SNORD116 activates the maternal transcripts in Prader-Willi syndrome neurons.

Authors:  Maéva Langouët; Dea Gorka; Clarisse Orniacki; Clémence M Dupont-Thibert; Michael S Chung; Heather R Glatt-Deeley; Noelle Germain; Leann J Crandall; Justin L Cotney; Christopher E Stoddard; Marc Lalande; Stormy J Chamberlain
Journal:  Hum Mol Genet       Date:  2020-11-25       Impact factor: 6.150

4.  Inactivating NHLH2 variants cause idiopathic hypogonadotropic hypogonadism and obesity in humans.

Authors:  A Kemal Topaloglu; Enver Simsek; Matthew A Kocher; Jamala Mammadova; Ece Bober; Leman Damla Kotan; Ihsan Turan; Can Celiloglu; Fatih Gurbuz; Bilgin Yuksel; Deborah J Good
Journal:  Hum Genet       Date:  2022-01-23       Impact factor: 5.881

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.